{"id":346801,"date":"2025-08-27T05:03:09","date_gmt":"2025-08-27T05:03:09","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/346801\/"},"modified":"2025-08-27T05:03:09","modified_gmt":"2025-08-27T05:03:09","slug":"vih-la-commercialisation-du-traitement-preventif-prometteur-de-gilead-validee-par-lunion-europeenne-le-monde-fr","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/346801\/","title":{"rendered":"VIH : la commercialisation du traitement pr\u00e9ventif prometteur de Gilead valid\u00e9e par l\u2019Union europ\u00e9enne &#8211; Le Monde.fr"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi_gFBVV95cUxPaC1YeWwyczU3Z0pFdTFUak5jcnlHQlJmc1o5Wjc0dERrejFDZTdoaGlFS3VfdkpFUkVoaDNJSnA1UzRqeEJJMW5LN2UxVTdFbUxMNUt4ekxFYUNuS3FDQkZETW1hRFJjb1JPdUxURVZUUHhMSHpaNVFXOVg3WUp4c0FQMHNGNzR0ZTFyRVd2V2xvcDFzZUxSWlk1dFVYQU5STHIwT0tvUVNLNkE3eENhOTFQM0VwZ1QyQVM0Y0pJNlYxVEdhbkhKdHFwNC1wdW9pZE9ERkN0MHpSSEx2UkYxQlE5ajZ2SFpqOHVqXzUxSE9HamhlOTVGQ2lhcGVVZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">VIH : la commercialisation du traitement pr\u00e9ventif prometteur de Gilead valid\u00e9e par l\u2019Union europ\u00e9enne<\/a>&nbsp;&nbsp;Le Monde.fr<\/li>\n<li><a href=\"https:\/\/news.google.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?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">L&rsquo;UE approuve la nouvelle injection de Gilead pour la pr\u00e9vention du VIH<\/a>&nbsp;&nbsp;Boursorama<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMipgFBVV95cUxNbXpWMUZPLXFfOTdlQk1zVUxWa3hkaDNmbzNGeW01TnVqbnA0Tl9FSWFYZVpJVkN5YVBuR19EZnNKTURLRG5XWTRUNUgyVm50b28zOENMcHVJNVJUYTVMZFRXMEo4LXFTSzRvOUE3OHpwQktIbmtYMFBZY0hqYTduNC13OVEyOWpoSHBzcHFZem9BeG82YVhaWEp0M2hOMG5RTFFlYWhn?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">L&rsquo;UE donne son feu vert au Yeytuo, un traitement pr\u00e9ventif contre le VIH<\/a>&nbsp;&nbsp;Le Temps<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi7wFBVV95cUxNUFB1VFZOOHl4dDNDS3NkU3JhbVp3U3V5ZzhMMFd4SHZyWkotZHpXWllFUXcxbkxOaWZXMnZoN1Q1WlFaTk1KY2hBcjhOcVJoVmlfY0F5OTFlaWxmcVVQUVFoMnBicXQtLUFYc1dwMXZxNVZnN3otLUU5d3c0SHhCczBfanMtdjI0QVR5TGlYcUVhVHdka1BuLXBnTnlJSmVCd2M2bllrRkhCX2tkRnM0bFVpWXhreWQ3cmFvdFZnclRqdEs1VWZsdGdfeWZfQmZUY01WTkVtcTFDdTJCUGFpLXVoSkNuSm0tTkR6T0hlNA?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">La Commission europ\u00e9enne autorise le Yeytuo de Gilead Sciences, \u00e0 prise semestrielle, pour la pr\u00e9vention du VIH<\/a>&nbsp;&nbsp;Zonebourse Suisse<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMizwFBVV95cUxQZ1ZGZ09fSzVnTm1DRk12UTVVU2s5TTdBZHlFa1hUTGgyUV8tXzYxSm45ZGVEUDBSQ2dtM1BkcUl4N1hQUkNWaExBcGRJSi1icXdIRW9oeFdRb2U1aDl3Umd4b2JBOGNjek5vTDRFNVZGQ2hON2k2SnJYRDR2QzNyWFhmVl9NRTlxOGNWN0ZNMHdwdU1vQlZWZ3dVc3I0STU0QU9uc3J4UDZlZ0JmbHF6Um1JQ0lMY3FMMmxYdDVZZFM2VnllS28tSG5GMDJxNFU?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">CVS Health nie la couverture des m\u00e9dicaments contre le VIH perc\u00e9s, commettant une \u00abviolation claire\u00bb de l&rsquo;ACA<\/a>&nbsp;&nbsp;mygayprides.com<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"VIH : la commercialisation du traitement pr\u00e9ventif prometteur de Gilead valid\u00e9e par l\u2019Union europ\u00e9enne&nbsp;&nbsp;Le Monde.fr L&rsquo;UE approuve la&hellip;\n","protected":false},"author":2,"featured_media":1445,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[35,33,34,1011,27],"class_list":{"0":"post-346801","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie","8":"tag-business","9":"tag-economie","10":"tag-economy","11":"tag-fr","12":"tag-france"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115098983080836140","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/346801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=346801"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/346801\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/1445"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=346801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=346801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=346801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}